Greg Hurlbut

Grundare på SIONNA THERAPEUTICS, INC.

Consumer Services

Health Technology

Profil

Greg Hurlbut is the founder of Sionna Therapeutics, Inc. since 2019, holding the title of Senior Vice President-Discovery Research.
Former job includes Head-Protein Conformational Diseases at Genzyme Therapeutics Ltd. Education includes an undergraduate degree from the University of Massachusetts and a doctorate from Université Paris-Saclay.

Aktiva positioner av Greg Hurlbut

Företag	Position	Start
SIONNA THERAPEUTICS, INC.	Grundare	2019-08-01

Alla aktiva positioner av Greg Hurlbut

Tidigare kända positioner av Greg Hurlbut

Företag	Position	Slut
Genzyme Therapeutics Ltd. Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases	Företagsledare/Principal	-

Se detaljerna i Greg Hurlbuts erfarenhet

Greg Hurlbuts utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Greg Hurlbuts erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	4
University of Massachusetts University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Genzyme Therapeutics Ltd. Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases	Health Technology
Université Paris-Saclay Université Paris-Saclay Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sionna Therapeutics, Inc. Sionna Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for CF and rare diseases	Health Technology